Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
March-2022 Volume 16 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2022 Volume 16 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Rhizopus oryzae AM16; a new hyperactive L‑asparaginase producer: Semi solid‑state production and anticancer activity of the partially purified protein

  • Authors:
    • Sarah I. Othman
    • Amal A.I. Mekawey
    • Mohammad M. El‑Metwally
    • Sami A. Gabr
    • Maha Abdulla Alwaele
    • Haifa Al Fassam
    • Rasha Abo‑Eleneen
    • Ahmed A. Allam
    • Wesameldin I.A. Saber
  • View Affiliations / Copyright

    Affiliations: Department of Biology, Faculty of Science, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia, The Regional Center of Mycology and Biotechnology, Al‑Azhar University, Cairo 11765, Egypt, Botany and Microbiology Department, Faculty of Science, Damanhour University, Damanhour 22511, Egypt, Department of Anatomy and Embryology, Faculty of Medicine, Mansoura University, Mansoura 35511, Egypt, Zoology Department, Faculty of Science, Beni‑Suef University, Beni‑Suef 62511, Egypt, Microbial Activity Unit, Department of Microbiology, Soils, Water and Environment Research Institute, Agricultural Research Center, Giza 12619, Egypt
    Copyright: © Othman et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 15
    |
    Published online on: January 14, 2022
       https://doi.org/10.3892/br.2022.1498
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The demand for L‑asparaginase is predicted to increase several fold in the future due to its potential clinical applications in the treatment of lymphoid system malignancies and leukemia. Thus identifying suitable sources of production should be considered high priority. Fungi are valuable organisms as they are able to convert what would be considered ‘useless’ materials into materials that have potential value. The present study provides a proof of concept of production of a new hyperactive L‑asparaginase producer (Rhizopus oryzae AM16), which was successfully isolated and sequentially optimized using a semi solid‑state fermentation method with a simple and cheap medium produced from wheat bran (WB). The fungus was able to produce an appreciable amount of the enzyme (2,875.9 U) after 8 days of incubation under 85.7% moisture, in the presence of magnesium nitrate (5.0 mg N/mg nitrogen per gram of dry WB) at pH 5.8. Testing the anticancer activity confirmed the ability of the resultant enzyme to inhibit the growth of various types of cancer cells (HepG2, MCF‑7, HCT and A549). The IC50 values of the dialyzed enzyme were lower than that of the crude product. Thus, this newly identified and purified L‑asparaginase may be a promising anticancer drug.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Cooper GM: The development and causes of cancer. In: The Cell: A Molecular Approach. 2nd edition. Sinauer Associates, Sunderland, MA, 2000.

2 

Ramya LN, Doble M, Rekha VPB and Pulicherla KK: L-Asparaginase as potent anti-leukemic agent and its significance of having reduced glutaminase side activity for better treatment of acute lymphoblastic leukaemia. Appl Biochem Biotechnol. 167:2144–2159. 2012.PubMed/NCBI View Article : Google Scholar

3 

Kebeish R, El-Sayed A, Fahmy H and Abdel-Ghany A: Molecular cloning, biochemical characterization, and antitumor properties of a novel L-asparaginase from Synechococcuselongatus PCC6803. Biochemistry (Mosc). 81:1173–1181. 2016.PubMed/NCBI View Article : Google Scholar

4 

Naser S, Saber W, El-Metwally M, Moustafa M and El-Kott A: Fungal assembly of L-asparaginase using solid-state fermentation: A review. Biocell. 44(147)2020.

5 

Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P, Benoit Y, Robert A, Manel AM, Vilmer E, et al: Comparison of Escherichia coli-asparaginase with Erwinia-asparaginasein the treatment of childhood lymphoid malignancies: Results of a randomized European Organisation for research and treatment of Cancer-Children's Leukemia Group phase 3 Trial. Blood. 99:2734–2739. 2002.PubMed/NCBI View Article : Google Scholar

6 

Verma N, Kumar K, Kaur G and Anand S: L-asparaginase: A promising chemotherapeutic agent. Crit Rev Biotechnol. 27:45–62. 2007.PubMed/NCBI View Article : Google Scholar

7 

Kornbrust BA, Stringer MA, Lange NE, Hendriksen HV, Whitehurst R and Oort MV: Asparaginase-an enzyme for acrylamide reduction in food products. In: Enzymes in Food Technology. 2nd edition, pp59-87, 2010.

8 

Batool T, Makky EA, Jalal M and Yusoff MM: A comprehensive review on L-Asparaginase and its applications. Appl Biochem Biotechnol. 178:900–923. 2016.PubMed/NCBI View Article : Google Scholar

9 

Vivekanandha S, Muruganantham S and Paulraj P: Anovel role of L-asparaginase enzyme production from fungal species. J Microbiol Biotechnol Res. 3:7–14. 2013.

10 

Thomas L, Larroche C and Pandey A: Current developments in solid-state fermentation. Biochem Eng J. 81:146–161. 2013.

11 

Sreenivasulu V, Jayaveera KN and Rao PM: Solid-state fermentation for the production of L-asparaginase by Aspergillus sp. J Pharmacogn Phytochem. 1:21–25. 2009.

12 

Doriya K and Kumar DS: Optimization of solid substrate mixture and process parameters for the production of L-asparaginase and scale-up using tray bioreactor. Biocatalysis Agricultural Biotechnol. 13:244–250. 2018.

13 

Apprich S, Tirpanalan O, Hell J, Reisinger M, Böhmdorfer S, Siebenhandl-Eh S, Novalin S and Kneifel W: Wheat bran-based biorefinery 2: Valorization of products. LWT-Food Sci Technol. 56:222–231. 2014.

14 

Prueckler M, Siebenhandl-Ehn S, Apprich S, Hoeltinger S, Haas C, Schmid E and Kneifel W: Wheat bran-based biorefinery 1: Composition of wheat bran and strategies of functionalization. LWT-Food Sci Technol. 56:211–221. 2014.

15 

Andersson AA, Dimberg L, Åman P and Landberg R: Recent findings on certain bioactive components in whole grain wheat and rye. J Cereal Sci. 59:294–311. 2014.

16 

De Brier N, Hemdane S, Dornez E, Gomand SV, Delcour JA and Courtin CM: Structure, chemical composition and enzymatic activities of pearlings and bran obtained from pearled wheat (Triticumaestivum L.) by roller milling. J Cereal Sci. 62:66–72. 2015.

17 

Babu CR, Ketanapalli H, Beebi SK and Kolluru VC: Wheat bran-composition and nutritional quality: A review. Adv Biotechnol Micro. 9(555754)2018.

18 

Pandey A, Soccol CR, Rodriguez-Leon JA and Nigam PSN: Solid-state fermentation in biotechnology: Fundamentals and applications. Asiatech Publishers, Inc., New Delhi, 2001.

19 

Economou CN, Makri A, Aggelis G, Pavlou S and Vayenas DV: Semi-solid state fermentation of sweet sorghum for the biotechnological production of single cell oil. Bioresource Technol. 101:1385–1388. 2010.PubMed/NCBI View Article : Google Scholar

20 

Reid Y, Storts D, Riss T, Minor L, Markossian S, Grossman A, Brimacombe K, Arkin M, Auld D, Austin CP, et al: Authentication of human cell lines by STR DNA profiling analysis. In: Assay Guidance Manual. Markossian S, Grossman A, Brimacombe K, et al (eds). Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda, MD, 2004.

21 

Gulati R, Saxena RK and Gupta R: A rapid plate assay for screening L-asparaginase producing micro-organisms. Lett Appl Micro. 24:23–26. 1997.PubMed/NCBI View Article : Google Scholar

22 

Raper KB, Austwick PK and Fennell DI: The Genus Aspergillus. R.E. Krieger, Malabar, FL, 1977.

23 

Pitt JI: The genus Penicillium and its teleomorphic states Eupenicillium and Talaromyces. Academic Press, London and New York, 1979.

24 

Pitt JI: A Laboratory Guide to Common Penicillium Species. Commonwealth Scientific and Industrial Research. North Ryde, 1986.

25 

Kitch MA and Pitt JI: A laboratory guide to the common Aspergillus species and their Teleomorphs. Published by Commonwealth Scientific and Industrial Research Organization. Division of Food Processing, Sydney, 1992.

26 

Kubicek CP and Harman GE: Trichoderma and Gliocladium. Taylor and Francis Ltd., London and Bristol, 1998.

27 

Domsch KH, Gams W and Anderson TH: Compendium of Soil Fungi. Academic Press, London, 1980.

28 

Baskar G and Renganathan S: Production of L-asparaginase from natural substrates by Aspergillus terreus MTCC 1782: Optimization of carbon source and operating conditions. Int J Chem Reactor Engineering: Oct 18, 2011 (Epub ahead of print). doi: 10.1515/1542-6580.2479.

29 

Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254. 1976.PubMed/NCBI View Article : Google Scholar

30 

Cheng YL, Chang WL, Lee SC, Liu YG, Lin HC, Chen CJ, Yen CY, Yu DS, Lin SZ and Harn HJ: Acetone extract of Bupleurum scorzonerifolium inhibits proliferation of A549 human lung cancer cells via inducing apoptosis and suppressing telomerase activity. Life Sci. 73:2383–2394. 2003.PubMed/NCBI View Article : Google Scholar

31 

Indira K, Jayaprabha N, Balakrishnan S, Arulmoorthy MP and Srinivasan M: Production, purification and characterisation of extracellular L-asparaginase from salt marsh fungal endophytes. J Pharm Pharmac Sci. 4:663–677. 2015.

32 

Thirunavukkarasu N, Suryanarayanan TS, Murali TS, Ravishankar JP and Gummadi SN: L-asparaginase from marine derived fungal endophytes of seaweeds. Mycosphere. 2:147–155. 2011.

33 

Theantana T, Hyde KD and Lumyong S: Asparaginase production by endophytic fungi from Thai medicinal plants: Cytotoxicity properties. Int J Integrative Biol. 7:1–8. 2009.

34 

Ahmad N, Pandit NP and Maheshwari SK: L-asparaginase gene-a therapeutic approach towards drugs for cancer cell. Int J Biosci. 2:1–11. 2012.

35 

Shakambari G, Ashokkumar B and Varalakshmi P: L-asparaginase-A promising biocatalyst for industrial and clinical applications. Biocatalysis Agricultural Biotechnol. 17:213–224. 2019.

36 

Tippani R and Sivadevuni G: Nutritional factors effecting the production of L-asparaginase by the Fusarium sp. Afr J Biotechnol. 11:3692–3696. 2012.

37 

Uppuluri KB and Reddy DS: Optimization of L-asparaginase production by isolated Aspergillusniger using sesame cake in a column bioreactor. J Pure Appl Microbiol. 3:83–90. 2009.

38 

Singh SB, Bais BS and Singh DR: Effect of different carbon and nitrogen sources on the growth and sporulation of Claviceps microcephal (Wallr.) TUL. Mycopathol Mycol Appl. 46:373–378. 1972.PubMed/NCBI View Article : Google Scholar

39 

Selvaraj S and Murty VR: Semi-solid state fermentation: A promising method for production and optimization of tannase from Bacillus gottheilii M2S2. Res J Biotechnol. 12:39–48. 2017.

40 

Abdel-Fattah YR and Olama ZA: L-asparaginase production by Pseudomonas aeruginosa in solid-state culture: Evaluation and optimization of culture conditions using factorial designs. Process Biochemistry. 38:115–122. 2002.

41 

Reid ID: Solid-state fermentations for biological delignification. Enzyme Micro Technol. 11:786–803. 1989.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Othman SI, Mekawey AA, El‑Metwally MM, Gabr SA, Alwaele MA, Al Fassam H, Abo‑Eleneen R, Allam AA and Saber WI: <em>Rhizopus oryzae</em> AM16; a new hyperactive L‑asparaginase producer: Semi solid‑state production and anticancer activity of the partially purified protein. Biomed Rep 16: 15, 2022.
APA
Othman, S.I., Mekawey, A.A., El‑Metwally, M.M., Gabr, S.A., Alwaele, M.A., Al Fassam, H. ... Saber, W.I. (2022). <em>Rhizopus oryzae</em> AM16; a new hyperactive L‑asparaginase producer: Semi solid‑state production and anticancer activity of the partially purified protein. Biomedical Reports, 16, 15. https://doi.org/10.3892/br.2022.1498
MLA
Othman, S. I., Mekawey, A. A., El‑Metwally, M. M., Gabr, S. A., Alwaele, M. A., Al Fassam, H., Abo‑Eleneen, R., Allam, A. A., Saber, W. I."<em>Rhizopus oryzae</em> AM16; a new hyperactive L‑asparaginase producer: Semi solid‑state production and anticancer activity of the partially purified protein". Biomedical Reports 16.3 (2022): 15.
Chicago
Othman, S. I., Mekawey, A. A., El‑Metwally, M. M., Gabr, S. A., Alwaele, M. A., Al Fassam, H., Abo‑Eleneen, R., Allam, A. A., Saber, W. I."<em>Rhizopus oryzae</em> AM16; a new hyperactive L‑asparaginase producer: Semi solid‑state production and anticancer activity of the partially purified protein". Biomedical Reports 16, no. 3 (2022): 15. https://doi.org/10.3892/br.2022.1498
Copy and paste a formatted citation
x
Spandidos Publications style
Othman SI, Mekawey AA, El‑Metwally MM, Gabr SA, Alwaele MA, Al Fassam H, Abo‑Eleneen R, Allam AA and Saber WI: <em>Rhizopus oryzae</em> AM16; a new hyperactive L‑asparaginase producer: Semi solid‑state production and anticancer activity of the partially purified protein. Biomed Rep 16: 15, 2022.
APA
Othman, S.I., Mekawey, A.A., El‑Metwally, M.M., Gabr, S.A., Alwaele, M.A., Al Fassam, H. ... Saber, W.I. (2022). <em>Rhizopus oryzae</em> AM16; a new hyperactive L‑asparaginase producer: Semi solid‑state production and anticancer activity of the partially purified protein. Biomedical Reports, 16, 15. https://doi.org/10.3892/br.2022.1498
MLA
Othman, S. I., Mekawey, A. A., El‑Metwally, M. M., Gabr, S. A., Alwaele, M. A., Al Fassam, H., Abo‑Eleneen, R., Allam, A. A., Saber, W. I."<em>Rhizopus oryzae</em> AM16; a new hyperactive L‑asparaginase producer: Semi solid‑state production and anticancer activity of the partially purified protein". Biomedical Reports 16.3 (2022): 15.
Chicago
Othman, S. I., Mekawey, A. A., El‑Metwally, M. M., Gabr, S. A., Alwaele, M. A., Al Fassam, H., Abo‑Eleneen, R., Allam, A. A., Saber, W. I."<em>Rhizopus oryzae</em> AM16; a new hyperactive L‑asparaginase producer: Semi solid‑state production and anticancer activity of the partially purified protein". Biomedical Reports 16, no. 3 (2022): 15. https://doi.org/10.3892/br.2022.1498
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team